Organon & Co.
A global healthcare company focused on women's health, biosimilars, and established brands worldwide.
OGN | NYSE
Overview
Corporate Details
- ISIN(s):
- US68622V1061
- LEI:
- Country:
- United States of America
- Address:
- 30 HUDSON STREET, 7302 JERSEY CITY
- Website:
- https://www.organon.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Organon & Co. is a global healthcare company with a dedicated focus on improving women's health. Spun off from Merck, the company operates with a diverse portfolio structured across three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division develops medicines and devices for reproductive health, including contraception, fertility, and maternal health. The Biosimilars segment works to provide more accessible treatment options, while the Established Brands portfolio includes a wide range of therapies for conditions in areas like cardiovascular disease, respiratory health, and dermatology. Organon delivers its portfolio of over 70 products to patients and providers in more than 140 markets worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Organon & Co. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Organon & Co.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Organon & Co. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
